Investing
Castlight, Achaogen, Dipexium, Galmed: The Week’s IPOs
Published:
Last Updated:
Source: Thinkstock
Castlight Health Inc. (NYSE: CSLT) was easily the most anticipated and the most successful of of the IPOs. The healthcare software provider sold 11.1 million class B shares at $16 a share, much higher than the original expected range of $9 to $11 and above a Tuesday revision that raised the range to $13 to $15 a share. Friday’s IPO raised net proceeds of around $161 million based on the IPO price. Shares closed at $39.80, up 148.75% from the IPO price. The shares reached as high as $41.95 a share early in the day.
Achaogen Inc. (NASDAQ: AKAO) priced its Wednesday IPO of 6 million shares at $12 a share, the low end of its expected range. The development stage drug company is working on antibiotics to treat drug-resistant infections. Shares jumped 19% on Wednesday, closing at $14.31 and have since added nearly an additional $2 a share to close at $16.16 on Friday. While that was down 1.1% from Thursday, the shares ended the week up nearly 35% from the IPO.
Dipexium Pharmaceuticals Inc. (NASDAQ: DPRX) held its IPO on Thursday after pricing 2.75 million shares at $12 a share, again the low end of its expected range. Dipexium is a late-stage biopharma that is developing a treatment for mild infections of diabetic foot ulcers. Shares closed at $14.04 on the first day of trading, but lost more than 4.5% on Friday to close at $13.40.
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) priced its Thursday IPO at $13.50 a share for 2.84 million shares, slightly above the mid-point of its expected range of $12 to $14 a share. Galmed is a clinical-stage biopharmaceutical company that is developing a once-a-day oral therapy for treatment of liver diseases and cholesterol gallstones. Shares closed at $14.31 on Thursday and rose nearly 2.4% to close at $14.65 on Friday. The stock price peaked at $18.73 on Thursday.
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
